Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial

Keyphrases

• Clinical Trials 100%
• Evacuation 100%
• Intracerebral Hemorrhage 100%
• Minimally Invasive Surgery 100%
• Recombinant Tissue Plasminogen Activator (rt-PA) 100%
• MISTIE 100%
• Clot 57%
• Medical Management 42%
• Clot Resolution 42%
• Catheter Placement 28%
• Brain Tissue 14%
• Adverse Events 14%
• Catheter 14%
• Surgical Intervention 14%
• Hematoma 14%
• Young Patients 14%
• Brain Injury 14%
• Medically Managed 14%
• Aggressive Treatment 14%
• Blood Clot 14%
• 30-day Mortality 14%
• Ischemic Stroke 14%
• Rebleeding 14%
• Cerebral Tissue 14%
• Blood Exposure 14%
• Clot Volume 14%
• Safety Limits 14%
• Clot Aspiration 14%
• Acute Treatment Phase 14%
• Resolution Rate 14%
• ICU Protocols 14%
• Spontaneous Drainage 14%
• Bacterial Ventriculitis 14%

Medicine and Dentistry

• Minimally Invasive Procedure 100%
• Clinical Trial 100%
• Evacuation 100%
• Cerebral Hemorrhage 100%
• Alteplase 100%
• Injection 28%
• Brain Ischemia 14%
• Adverse Event 14%
• Bleeding 14%
• Hematoma 14%
• Brain Injury 14%
• Brain Tissue 14%
• Blood Clot 14%
• Brain Ventriculitis 14%
• Table Salt 14%

Neuroscience

• Cerebral Hemorrhage 100%
• Alteplase 100%
• Brain Ischemia 14%
• Hematoma 14%
• Brain Injury 14%
• Ventriculitis 14%